iRhythm Holdings (IRTC) Free Cash Flow Growth (1y) (2016 - 2026)
iRhythm Holdings (IRTC) Free Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 133.09% |
| 10 | iRhythm Holdings | 3.65 Bn | 3.10 Bn | 141.35 Mn | -293.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -293.10% |
| Dec 31, 2025 | 15.94% |
| Sep 30, 2025 | 78.32% |
| Jun 30, 2025 | -57.00% |
| Mar 31, 2025 | 88.41% |
| Dec 31, 2024 | 159.65% |
| Sep 30, 2024 | 97.14% |
| Jun 30, 2024 | 272.66% |
| Mar 31, 2024 | -57.76% |
| Dec 31, 2023 | -210.00% |
| Sep 30, 2023 | 197.33% |
| Jun 30, 2023 | -966.67% |
| Mar 31, 2023 | 11.88% |
| Dec 31, 2022 | 238.40% |
| Sep 30, 2022 | -442.82% |
| Jun 30, 2022 | 111.21% |
| Mar 31, 2022 | -4.32% |
| Dec 31, 2021 | 90.47% |
| Sep 30, 2021 | -18.20% |
| Jun 30, 2021 | 27.92% |